Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Lose Big After Ctrip $CTRP Share Prices Fall Over 12%

Ctrip.com (CTRP) share prices fell over 12% on Monday after reporting a disappointing sales outlook for the fourth quarter. Afterwards, analysts at Brean Murray Carret downgraded the company to hold. CTRP share prices fell from $34.27 at close Friday to trade at just $30.05 at 2pm EST.

LONE PINE CAPITAL

The following hedge funds lost the most:

1. Lone Pine Capital – Stephen Mandel: Lost $34.1 million

2. Conatus Capital Management – David Stemerman: Lost $10.8 million

3. Brookside Capital – Bain Capital: Lost $8.9 million

4. Chilton Investment Company – Richard Chilton: Lost $1.7 million

5. Sloane Robinson Investment Management – Hugh Sloane: Lost $1.6 million

6. Kleinheinz Capital Partners – John Kleinheinz: Lost $1.2 million

7. Bridger Management – Roberto Mignone: Lost $760,000

8. White Elm Capital – Matthew Iorio: Lost $470,00

9. Millennium Management – Israel Englander: Lost $317,000

10. Crosslink Capital – Seymour Sy Kaufman and Michael Stark: Lost $257,000

11. D E Shaw – D. E. Shaw: Lost $206,000

12. Citadel Investment Group – Ken Griffin: Lost $167,000

13. Soros Fund Management – George Soros: Lost $130,000

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in CTRP since the end of June. We did not take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!